secwatch.observer — SEC 8-K summary
======================================

Issuer:     Teladoc Health, Inc. (TDOC)
CIK:        0001477449
Form:       8-K
Filed at:   2025-07-29T23:59:59+00:00
Accession:  0001477449-25-000096
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Teladoc Q2 revenue $631.9M (-2% YoY); adjusted EBITDA $69.3M (-23%); retires $550.6M convertible notes
--------------------------------------------------------------------------------

- Net loss of $32.7M ($0.19 per share), improved from $837.7M loss in Q2 2024 which included $790M goodwill impairment.
- Integrated Care segment revenue $391.5M (+4% YoY); BetterHelp revenue $240.4M (-9% YoY).
- Paid $550.6M cash to retire convertible notes; entered a five-year $300M secured revolving credit facility on July 17.
- Full-year 2025 revenue guidance $2,501–$2,548M; adjusted EBITDA $263–$294M; Q3 revenue guidance $614–$636M.
- Free cash flow $61.2M in Q2 vs. $60.9M in Q2 2024; Capex $30.2M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1477449/000147744925000096/0001477449-25-000096-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1477449/000147744925000096/tdoc-20250729.htm
  HTML page:      https://secwatch.observer/filing/0001477449-25-000096

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer